Form 8-K - Current report:
SEC Accession No. 0000947871-99-000179
Filing Date
1999-05-04
Accepted
1999-05-04 00:00:00
Documents
5
Period of Report
1999-04-28
Items
Item 5: Other events
Item 7: Financial statements and exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K 8-K 5924
2 AGREEMENT AND PLAN OF MERGER EX-2.1 303025
3 STOCK OPTION AGREEMENT EX-4.1 50761
4 STOCK OPTION AGREEMENT EX-10.1 50785
5 PRESS RELEASE EX-99.1 9417
  Complete submission text file 0000947871-99-000179.txt   421910
Mailing Address CORNING PHARMACEUTICAL SERVICES INC 210 CARNEGIE CENTER PRINCETON NJ 08540
Business Address 210 CARNEGIE CENTER PRINCETON NJ 08540 6094528550
COVANCE INC (Filer) CIK: 0001023131 (see all company filings)

EIN.: 223265977 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12213 | Film No.: 99609862
SIC: 8731 Services-Commercial Physical & Biological Research